| Code | Description | Claims | Beneficiaries | Total Paid |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
237 |
67 |
$23K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
396 |
148 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
744 |
252 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,112 |
304 |
$5K |
| 99442 |
|
315 |
139 |
$2K |
| 99441 |
|
19 |
19 |
$180.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
340 |
121 |
$160.00 |
| 86701 |
|
39 |
38 |
$0.00 |